Therapeutic Benefits of Tocilizumab Vary in Different Organs of a Patient with AA Amyloidosis
Figure 1
Endoscopic gastric biopsy. (a) Congo red staining shows amorphous amyloid deposits in the gastric mucosa. (b) After 4 years of tocilizumab treatments, regression of the amyloid deposition was noted.
